DIMS: Bangladesh's Leading Offline Mobile Drug Index
DIMS is the ultimate offline mobile drug index for Bangladesh, offering healthcare and pharmaceutical professionals instant access to crucial clinical drug information. Developed by ITmedicus, this comprehensive and regularly updated app provides quick access to details on over 28,000 brand-name and 2228+ generic drugs.
Key Features:
- Comprehensive Drug Information: Access detailed drug information including indications, dosage, administration, contraindications, side effects, precautions, warnings, FDA pregnancy category, therapeutic class, pack size, and price.
- Multiple Search Options: Search for drugs by brand name, generic name, or condition. Browse drugs alphabetically by brand or generic name, or by class or condition.
- Personalized Features: Bookmark favorite brand names for quick access and receive updates on international medical events.
- Advanced Search & Analysis: Utilize advanced search filters for targeted results. Access disease details, national and international guidelines, information on herbal brands, and mini-Rx resources. Stay up-to-date with practice updates.
- Feedback Mechanism: Share your valuable feedback, suggestions, and comments directly through the app.
Disclaimer:
DIMS serves as a reference tool and educational resource only. It is not intended to provide medical advice, diagnosis, or treatment, nor should it replace professional judgment. The information provided should supplement, not substitute, the expertise of qualified healthcare professionals (physicians, pharmacists, nurses, etc.) involved in patient care.
While DIMS utilizes reliable data sources and company literature, and significant effort is made to ensure accuracy, the publisher, authors, editors, and their representatives are not liable for any errors, omissions, inaccuracies, or consequences arising from the use of this app. Licensed medical professionals remain solely responsible for all medical judgments, diagnoses, and treatments, regardless of this app's use. Users acknowledge and agree that the app's content may contain inaccuracies or errors.
